COVID-19 News Updates

Biological E, the Hyderabad-based vaccine maker, expects the rollout of its Covid-19 vaccine 'Corbevax' by the end of November and is looking to supply nearly 10 crore doses on the day of its launch

Meanwhile, the new cases reported on Monday in the State stood at 425, including 71 children. The state has also recorded 4 fatalities. It is being observed that the daily cases in the State are oscillating between 400-500 since last month.

The Covid-19 pandemic has turned into an endemic and thus, the cases in the state will never be zero. Odisha Health Services Director, Bijay Mohapatra revealed this on Monday (Oct 25).

The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 102.27 crore.

In terms of infections, India follows in the second place with 34,175,468 cases.

According to the doctors, the patient affected by RSV will have a cough and cold in the first two days and then they will develop breathing problems, and, in some cases, it turns out to be serious.

The state's positivity rate now stands at 4.82 per cent.

Founded in 1953, Biological E claims to be the first private sector biological products company in India.

A decrease of 1,134 cases has been recorded in the total active number of COVID-19 cases in a span of 24 hours.

In terms of infections, India follows in the second place with 34,159,562 cases.

The Prime Minister also stressed that the country needs to institutionalise the best practices learnt during the last one and a half years, and said that this is an opportunity to modify our practices, in tune with the global standards.

All travellers with a 14-day travel history to Bangladesh, India, Myanmar, Nepal, Pakistan and Sri Lanka will be allowed to enter or transit through Singapore from Wednesday, the health ministry said.

Odisha currently has 4,581 active cases, while 603 people were cured of the disease on Friday, taking the total number of recoveries to 10,25,025.

A decrease of 2,017 cases has been recorded in the total active number of COVID-19 cases in a span of 24 hours.

If authorised, Pfizer-BioNTech vaccine would be the first Covid-19 vaccine for younger children.